"Cutting Edge Research therapy"

During the past decade, Ventura Clinical Trials conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 19 clinical trials were completed, i.e. on average, 65.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 13 clinical trials were completed. i.e. 185.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ventura Clinical Trials" #1 sponsor was "Pfizer" with 4 trials, followed by "Allakos Inc." with 2 trials sponsored, "Celgene" with 2 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ventura Clinical Trials" #1 collaborator was "Alfasigma S.p.A." with 1 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator, "Ironwood Pharmaceuticals, Inc." with 1 trials as a collaborator, "Loyola University Chicago" with 1 trials as a collaborator and "OpenBiome" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Ventura Clinical Trials" are "Ulcerative Colitis" (5 trials), "Gastroparesis" (3 trials), "Cardiovascular Disease" (2 trials), "Clostridium Difficile" (2 trials) and "Clostridium Difficile Infection" (2 trials). Many other conditions were trialed in "Ventura Clinical Trials" in a lesser frequency.

Most popular intervention types in "Ventura Clinical Trials" are "Drug" (31 trials), "Biological" (3 trials), "Other" (3 trials), "Device" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "AK002" (2 trials), "Etrolizumab" (2 trials), "GED-0301" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ventura Clinical Trials" are 35 trials for "All" genders.

Currently, there are NaN active trials in "Ventura Clinical Trials". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Ventura Clinical Trials, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Ventura Clinical Trials, 2 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".